Clinical and biochemical correlates of male hypogonadism in type 2 diabetes
Open Access
Abstract
Summary: The origin of hypogonadism, a condition including both symptoms and biochemical criteria of androgen deficiency, in type 2 diabetes is poorly known. In a cross‐sectional study of 267 unselected patients, we analyzed the potential correlation of several clinical and biochemical variables as well as chronic micro‐ and macrovascular diabetic complications with hypogonadism. Hypogonadism was present in 46 patients (17.2%) using a cutoff of total testosterone 10.4 nmol/L and in 31 (11.6%) with a cutoff of 8 nmol/L. Among these patients, hypogonadotropic hypogonadism was the most prevalent form (82.6%). Compared to eugonadal subjects, hypogonadal men had significantly lower glomerular filtration rate (67.1 ± 23.4 vs. 78.4 ± 24.6 mL/min/1.73 m2, p = 0.005) and higher prevalence of chronic kidney disease (43.5% vs. 20.4%, p = 0.002), abnormal liver function tests (26.7% vs. 12%, p = 0.019), and psychiatric treatment (23.9% vs. 10.4%, p = 0.025). Total testosterone levels correlated inversely with age (R = −0.164, p = 0.007), fasting blood glucose (R = −0.127, p = 0.037), and triglycerides (R = −0.134, p = 0.029) and directly with glomerular filtration rate (R = 0.148, p = 0.015). Calculated free testosterone and bioavailable testosterone correlated directly with hemoglobin (R = 0.171, p = 0.015 and R = 0.234, p = 0.001, respectively). Multivariate logistic regression analysis, after adjusting for relevant confounding variables, showed that age >60 years (OR = 3.58, CI 95% = 1.48–8.69, p = 0.005), body mass index >27 kg/m2 (OR = 2.85, CI 95% = 1.14–7.11, p = 0.025), hypertriglyceridemia (OR = 2.16, CI 95% = 1.05–4.41, p = 0.035), glomerular filtration rate 2 (OR = 2.51, CI 95% = 1.19–5.29, p = 0.015), and abnormal liver function tests (OR = 3.57, CI 95% = 1.48–8.60, p = 0.005) were independently associated with male hypogonadism. Although older age, body mass index, and hypertriglyceridemia have been previously related to hypogonadism, our results describe that chronic kidney disease and abnormal liver function tests are independently correlated with hypogonadism in type 2 diabetic men.Keywords
Funding Information
- Consejería de Educación, Junta de Castilla y León ((GR37))
This publication has 31 references indexed in Scilit:
- A low level of serum total testosterone is independently associated with nonalcoholic fatty liver diseaseBMC Gastroenterology, 2012
- Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes‐related quality of lifeClinical Endocrinology, 2012
- Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2010
- Hypothesis: Kisspeptin Mediates Male Hypogonadism in Obesity and Type 2 DiabetesNeuroendocrinology, 2010
- Testosterone Levels in Males with Type 2 Diabetes and Their Relationship with Cardiovascular Risk Factors and Cardiovascular DiseaseThe Journal of Sexual Medicine, 2010
- Testosterone Concentrations in Diabetic and Nondiabetic Obese MenDiabetes Care, 2010
- Low testosterone and anaemia in men with type 2 diabetesClinical Endocrinology, 2009
- The aging male hypothalamic–pituitary–gonadal axis: Pulsatility and feedbackMolecular and Cellular Endocrinology, 2009
- Investigation, treatment and monitoring of late-onset hypogonadism in malesEuropean Journal of Endocrinology, 2008
- Low Testosterone and High C-Reactive Protein Concentrations Predict Low Hematocrit in Type 2 DiabetesDiabetes Care, 2006